Skip to main content
Loading Events

« All Events

Dr. Megan Agajanian of Stanford presents

March 25 @ 4:00 pm - 5:00 pm

Megan Agajanian, PhD, seminar speaker

Megan Agajanian, PhD
Postdoctoral Scholar, Roel Nuuse Lab
Department of Developmental Biology
Stanford University

Seminar title: “TBD”

Please join us and show support for our seminar speakers!
(For those unable to attend, a zoom link is available upon request to Mimi Baltz.)

Host: Mike Emanuele

Megan is a postdoc in Roul Nouse’s lab, the person who first identified Wnt signaling in humans. She is a former Pharmacology student in the Emanuele Lab.  She has been funded by HHMI Gilliam and a K00 Award, and was selected for the NSF-ASCB FRED Program.

“My project focuses on TBX3 (T-Box Transcription Factor 3), one of the top ten mutated genes in breast cancer. TBX3 upregulation and loss of function mutations are identified in patients, raising the question: is TBX3 a proto-oncogene or tumor suppressor? My work in the Nusse lab will define the role of TBX3 in breast cancer progression and identify TBX3 targets that can be utilized as therapeutic targets in TBX3-associated breast cancer.” ~ https://nusselab.stanford.edu/people/megan-agajanian/

Details

Date:
March 25
Time:
4:00 pm - 5:00 pm
Event Category:

Organizer

Mimi Baltz
Email
my.le@unc.edu

Venue

1131 Bioinformatics
130 Mason Farm Rd
Chapel Hill, North Carolina 27514 United States
+ Google Map